Hallek M, Ando K, Eder M, Slattery K, Ajchenbaum-Cymbalista F, Griffin J D
Dana-Faber Cancer Institute, Boston, Massachusetts.
Leukemia. 1994 May;8(5):740-8.
Steel factor (SF) synergizes with a variety of hemopoietins to support the growth and differentiation of human progenitor cells. The human factor-dependent cell line MO7 has been used as a model to study the interaction of SF with other growth factors such as GM-CSF, because both factors support the proliferation of this cell line and are synergistic in combination. Previous studies have shown that this effect is not readily explained by the synergistic activation of early, cytosolic signal transduction intermediates such as tyrosine kinases, Raf-1, MAP2 kinase, or phospholipase C gamma. In an attempt to further explore the biological and biochemical mechanisms of the synergy between SF and GM-CSF, we examined the effects of these growth factors on the regulation of nuclear proto-oncogenes, cell cycle control genes, and G1-->S transition of MO7 cells. Individually, GM-CSF was a much more potent growth factor for MO7 cells than SF, particularly under serum-free conditions. Only GM-CSF, but not SF, was able to stimulate G1-->S transition of MO7 cells after factor deprivation for 24 h. Northern blot analyses showed also differential effects of GM-CSF and SF on the expression of some nuclear proto-oncogenes and G1 cyclins. GM-CSF (10 ng/ml), but not SF (20 ng/ml) increased the expression of c-myc and cyclin D2 mRNA, whereas both factors caused transient increases of c-fos and cyclin D3 mRNAs. When added simultaneously, GM-CSF and SF induced an at least additive increase of c-fos mRNA expression; this effect required the presence of fetal calf serum. No additive effects of GM-CSF and SF on c-myc, cyclin D2 or D3 mRNA expression were observed. C-jun and c-myb mRNAs were constitutively expressed in the MO7 cell line, but not further increased after stimulation with GM-CSF or SF for 15 min to 48 h. The inability of SF to induce growth promoting genes such as c-myc and cyclin D2 may explain why this cytokine does not support sustained proliferation of MO7 cells. These observations suggest that SF and GM-CSF exert different effects on the expression of genes involved in regulatory pathways of cell proliferation, but the molecular mechanism of synergy remains to be elucidated.
钢因子(SF)与多种造血因子协同作用,以支持人类祖细胞的生长和分化。人因子依赖细胞系MO7已被用作研究SF与其他生长因子(如GM-CSF)相互作用的模型,因为这两种因子都支持该细胞系的增殖,且联合使用时具有协同作用。先前的研究表明,这种效应不易通过早期胞质信号转导中间体(如酪氨酸激酶、Raf-1、MAP2激酶或磷脂酶Cγ)的协同激活来解释。为了进一步探索SF与GM-CSF协同作用的生物学和生化机制,我们研究了这些生长因子对MO7细胞核原癌基因、细胞周期调控基因以及G1期向S期转变的影响。单独而言,GM-CSF对MO7细胞来说是比SF更强效的生长因子,尤其是在无血清条件下。在因子剥夺24小时后,只有GM-CSF能够刺激MO7细胞从G1期向S期转变,而SF则不能。Northern印迹分析也显示GM-CSF和SF对一些核原癌基因和G1期细胞周期蛋白的表达有不同影响。GM-CSF(10 ng/ml)能增加c-myc和细胞周期蛋白D2 mRNA的表达,但SF(20 ng/ml)则不能,而两种因子都能使c-fos和细胞周期蛋白D3 mRNA短暂增加。当同时添加时,GM-CSF和SF至少能使c-fos mRNA表达呈加性增加;这种效应需要胎牛血清的存在。未观察到GM-CSF和SF对c-myc、细胞周期蛋白D2或D3 mRNA表达有相加作用。C-jun和c-myb mRNA在MO7细胞系中组成性表达,但在用GM-CSF或SF刺激15分钟至48小时后没有进一步增加。SF无法诱导c-myc和细胞周期蛋白D2等促进生长的基因,这可能解释了为什么这种细胞因子不支持MO7细胞的持续增殖。这些观察结果表明,SF和GM-CSF对参与细胞增殖调控途径的基因表达有不同影响,但协同作用的分子机制仍有待阐明。